Affiliation:
1. SomaLogic, Inc., Boulder, Colorado, USA
2. Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, Colorado, USA
Abstract
ABSTRACT
Direct pathogen detection in blood to diagnose active tuberculosis (TB) has been difficult due to low levels of circulating antigens or due to the lack of specific, high-affinity binding reagents and reliable assays with adequate sensitivity. We sought to determine whether slow off-rate modified aptamer (SOMAmer) reagents with subnanomolar affinity for
Mycobacterium tuberculosis
proteins (antigens 85A, 85B, 85C, GroES, GroEL2, DnaK, CFP10, KAD, CFP2, RplL, and Tpx) could be useful to diagnose tuberculosis. When incorporated into the multiplexed, array-based proteomic SOMAscan assay, limits of detection reached the subpicomolar range in 40% serum. Binding to native
M. tuberculosis
proteins was confirmed by using
M. tuberculosis
culture filtrate proteins and fractions from infected macrophages and via affinity capture assays and subsequent mass spectrometry. Comparison of serum from culture-positive pulmonary TB patients and TB suspects systematically ruled out for TB revealed small but statistically significant (
P
< 0.0001) differences in the median
M. tuberculosis
signals and in specific pathogen markers, such as antigen 85B. Samples where many
M. tuberculosis
aptamers produced high signals were rare exceptions. In concentrated, protein-normalized urine from TB patients and non-TB controls, the CFP10 (EsxB) SOMAmer yielded the most significant differential signals (
P
< 0.0276), particularly in TB patients with HIV coinfection. In conclusion, direct
M. tuberculosis
antigen detection proved difficult even with a sensitive method such as SOMAscan, likely due to their very low, subpicomolar abundance. The observed differences between cases and controls had limited diagnostic utility in serum and urine, but further evaluation of
M. tuberculosis
SOMAmers using other platforms and sample types is warranted.
Funder
Bill and Melinda Gates Foundation
Publisher
American Society for Microbiology
Reference68 articles.
1. WHO. 2016. Global tuberculosis report. WHO, Geneva, Switzerland. http://www.who.int/tb/publications/global_report/en/.
2. Towards a point-of-care test for active tuberculosis: obstacles and opportunities
3. Tuberculosis diagnostics: which target product profiles should be prioritised?
4. Point-of-care tuberculosis diagnosis: are we there yet?
5. WHO. 2014. High-priority target product profiles for new tuberculosis diagnostics. WHO, Geneva, Switzerland. http://www.who.int/tb/publications/tpp_report/en/.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献